Skip to main content

Omacetaxine Dosage

Medically reviewed by Drugs.com. Last updated on Nov 28, 2023.

Applies to the following strengths: 3.5 mg

Usual Adult Dose for Chronic Myelogenous Leukemia

Induction dose: 1.25 mg/m2 subcutaneously twice daily for 14 consecutive days of a 28 day cycle.

Maintenance dose: 1.25 mg/m2 subcutaneously twice daily for 7 consecutive days of a 28 day cycle.

Use: Chronic or accelerated phase CML with resistance and/or intolerance to two or more tyrosine kinase inhibitors.

Comments: There are no trials verifying an improvement in disease-related symptoms or increased survival with omacetaxine.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

Precautions

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Reconstitution/preparation techniques:

Storage requirements (reconstituted):

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.